Opthea Announces Completion of Drug Substance Campaign
Filed with ASX · · 2 pages · English
Story so far
Earlier from Opthea
- Opthea Corporate Presentation - September 2024
- S&P DJI Announces September 2024 Quarterly Rebalance
- Opthea Reports Full-Year Results
- Opthea Preliminary Final and Annual Report
- Updated Quarterly Report and Cashflow
Later from Opthea
- Opthea Joins the S&P/ASX 300 Index
- Opthea EURetina Symposium 2024
- Opthea Corporate Presentation - Oct 2024
- Chair's Address to Shareholders
- Opthea Received A$15.9 Million R&D Tax Incentive
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea